Darvon, Darvocet painkillers pulled from the U.S. market

The manufacturer of the painkillers agrees to stop marketing the drugs at the request of the FDA. The drugs' core compound, propoxyphene, has been linked to serious and sometimes fatal heart rhythm abnormalities.WASHINGTON — The maker of Darvon and Darvocet announced Friday that it will stop marketing the widely used painkillers in the U.S. because of a new study linking the active ingredient in the drugs to serious and sometimes fatal heart rhythm abnormalities.

Read the whole article on LA Times - Health

More from LA Times - Health